• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ALI's revenues surge in second quarter of 1998

Article

ALI's revenues surge in second quarter of 1998Canadian ultrasound miniPACS developer ALI Technologies is proving that the market for ultrasound miniPACS continues to be quite healthy. The Richmond, BC-based firm's second-quarter revenues soared

ALI's revenues surge in second quarter of 1998

Canadian ultrasound miniPACS developer ALI Technologies is proving that the market for ultrasound miniPACS continues to be quite healthy. The Richmond, BC-based firm's second-quarter revenues soared 66% compared with the same period last year.

For the quarter (end-March), revenues were $5.1 million (Canadian), compared with $3 million in 1997. Net income was $1.1 million, compared with $458,000 in 1997.

ALI installed 29 of its UltraPACS systems, including 15 departmental and 14 clinical-scale systems, during the period. The firm has also expanded its R&D space by 100%, production capacity by 200%, and service capacity by 150%.

In other ALI news, the company has grown its North American direct sales force by 50% to a total of nine people. The firm has also signed a letter of intent to acquire the assets and intellectual property of its European distributor, SeppMED. Diligence work is under way.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.